Search Results - "Sheela, Sheenu"
-
1
Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response
Published in Frontiers in oncology (15-01-2019)“…Measurable residual disease (MRD) testing after initial chemotherapy treatment can predict relapse and survival in acute myeloid leukemia (AML). However, it…”
Get full text
Journal Article -
2
Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia
Published in Clinical hematology international (01-03-2020)“…Therapy for those with relapsed or refractory acute myeloid leukemia is suboptimal. Studies have suggested that timed sequential salvage combination cytotoxic…”
Get full text
Journal Article -
3
Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated Fusarium solani infection
Published in Leukemia research reports (2017)“…Disseminated Fusarium infection is associated with high mortality in immunocompromised patients. Patients with acute myeloid leukemia (AML) often have an…”
Get full text
Journal Article -
4
Persistent Tn polyagglutination syndrome during febrile neutropenia: a case report and review of the literature
Published in Journal of medical case reports (14-01-2011)“…Tn polyagglutination syndrome is a rare disorder that has been reported on only a few occasions in the literature, and, to the best of our knowledge, never…”
Get full text
Journal Article -
5
Value in Oncology: Beware Putting Lipstick on a Pig
Published in JCO oncology practice (01-08-2020)Get more information
Journal Article -
6
When the Minimal Becomes Measurable
Published in Journal of clinical oncology (20-07-2016)Get full text
Journal Article -
7
Outcomes of Patients with Refractory Peripheral T-Cell Lymphoma, Angioimmunoblastic and Other Nodal Lymphomas of T Follicular Helper-Cell Origin (OPerA)
Published in Blood (13-11-2019)“…Introduction: T cell lymphomas are heterogenous with an overall poor prognosis. Peripheral T cell lymphoma not otherwise specified (PTCL-NOS) and…”
Get full text
Journal Article -
8
Comparative Outcomes of Relapsed Follicular Lymphoma Patients Treated with Novel Agents: A Multi-Center Analysis
Published in Blood (13-11-2019)“…Background: Follicular lymphoma (FL) is the most common indolent lymphoma and is generally characterized by prolonged survival with multiple relapses…”
Get full text
Journal Article -
9
Molecular testing during AML treatment for early prediction of clinical response
Published in Journal of clinical oncology (20-05-2018)“…Abstract only…”
Get full text
Journal Article -
10
Moving away (finally) from doublet therapy in lung cancer: immunotherapy and KEYNOTE-189
Published in Journal of thoracic disease (01-09-2018)Get full text
Journal Article -
11
Increased Frequencies of PD-1+ CD8+ Marrow-Infiltrating Lymphocytes Associated with Highly Clonal T-Lymphocyte Expansions in Relapsed and Refractory AML Patients but Not Healthy Adults
Published in Blood (02-12-2016)“…Immune checkpoint therapy, particularly inhibition of the PD-1 axis, has shown remarkable efficacy in multiple solid tumor types and some hematological…”
Get full text
Journal Article -
12